Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

Similar articles for PubMed (Select 9087987)

1.

A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.

Petzinger GM, Bressman SB.

Mov Disord. 1997 Mar;12(2):246-8. No abstract available.

PMID:
9087987
2.

Catastrophic reactions induced by tetrabenazine.

Bruneau MA, Lespérance P, Chouinard S.

Can J Psychiatry. 2002 Sep;47(7):683. No abstract available.

PMID:
12355681
3.

Tetrabenazine as a cause of neuroleptic malignant syndrome.

Ossemann M, Sindic CJ, Laterre C.

Mov Disord. 1996 Jan;11(1):95. No abstract available.

PMID:
8771075
4.

Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia.

Stevens E, Roman A, Houa M, Razavi D, Jaspar N.

Intensive Care Med. 1998 Apr;24(4):369-71.

PMID:
9609418
5.

Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism.

Giladi N, Melamed E.

Mov Disord. 1999 Jan;14(1):158-9. No abstract available.

PMID:
9918362
6.

Neuroleptic malignant syndrome occurring in a suspected case of systemic lupus erythematosus.

Sule A, Gohar S, Mittal G, Balakrishnan C, Mangat G, Joshi VR.

J Assoc Physicians India. 2000 Apr;48(4):437-8.

PMID:
11273184
7.

Fluoxetine and neuroleptic malignant syndrome.

Halman M, Goldbloom DS.

Biol Psychiatry. 1990 Sep 15;28(6):518-21.

PMID:
2223920
9.

Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol.

Ondo WG, Hanna PA, Jankovic J.

Am J Psychiatry. 1999 Aug;156(8):1279-81.

PMID:
10450276
10.

Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride.

Koch HJ, Szecsey A, Vogel M, Fischer-Barnicol D.

Int J Clin Pract. 2003 Mar;57(2):147-9.

PMID:
12661802
11.

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.

Kenney C, Hunter C, Jankovic J.

Mov Disord. 2007 Jan 15;22(2):193-7.

PMID:
17133512
12.

Tardive tourettism after exposure to neuroleptic therapy.

Bharucha KJ, Sethi KD.

Mov Disord. 1995 Nov;10(6):791-3. Review.

PMID:
8749999
13.

[Paroxetine-induced neuroleptic malignant syndrome].

Heinemann F, Assion HJ, Hermes G, Ehrlich M.

Nervenarzt. 1997 Aug;68(8):664-6. German.

PMID:
9380213
14.

Bilateral akinesia in drug-induced parkinsonism after a subthalamic lesion.

Kulisevsky J, Lima de Freitas M, Barraquer-Bordas L.

Mov Disord. 1994 Jan;9(1):111-2. No abstract available.

PMID:
8139592
15.

Neuroleptic malignant syndrome while on tiapride treatment.

Duarte J, Campos JM, Cabezas C, Sagredo V, Cortina J, Clavería LE.

Clin Neuropharmacol. 1996 Dec;19(6):539-40. No abstract available.

PMID:
8937795
16.

Neuroleptic malignant syndrome superimposed on tardive dyskinesia.

Haggerty JJ Jr, Bentsen BS, Gillette GM.

Br J Psychiatry. 1987 Jan;150:104-5.

PMID:
2888500
17.

Improvement of tardive dyskinesia with isosorbide dinitrate.

Gross L, Schorr L, Rosenblatt JE.

J Clin Psychopharmacol. 1986 Aug;6(4):247-8. No abstract available.

PMID:
3734146
18.

Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child.

Yoshikawa H, Watanabe T, Abe T, Oda Y, Ozawa K.

Brain Dev. 2000 Jun;22(4):256-8. Review.

PMID:
10838114
19.

Dyskinesia associated with fluvoxamine.

Arya DK, Szabadi E.

J Clin Psychopharmacol. 1993 Oct;13(5):365-6. No abstract available.

PMID:
8227498
20.

Pelvic dyskinesia with an outstanding response to tetrabenazine.

Alentorn A, Palasí A, Campdelacreu J, Bruna J, Calopa M, Rubio F.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):847-8. doi: 10.1016/j.pnpbp.2009.03.033. Epub 2009 Apr 5.

PMID:
19348867
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk